M&A Deal Summary

Triad Isotopes Acquires Low Country Diagnostics

On November 8, 2007, Triad Isotopes acquired life science company Low Country Diagnostics

Acquisition Highlights
  • This is Triad Isotopes’ 7th transaction in the Life Science sector.
  • This is Triad Isotopes’ 7th transaction in the United States.
  • This is Triad Isotopes’ 3rd transaction in South Carolina.

M&A Deal Summary
Date 2007-11-08
Target Low Country Diagnostics
Sector Life Science
Buyer(s) Triad Isotopes
Deal Type Add-on Acquisition

Target

Low Country Diagnostics

Charleston, South Carolina, United States
Low Country Diagnostics, Inc. is a nuclear pharmacy company.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Triad Isotopes

Orlando, Florida, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Triad Isotopes, Inc. is an independent nuclear pharmacy in the US that compounds and distributes radiopharmaceuticals used for both diagnostic imaging procedures and for treatment of certain diseases.

DEAL STATS #
Overall 7 of 7
Sector (Life Science) 7 of 7
Type (Add-on Acquisition) 7 of 7
State (South Carolina) 3 of 3
Country (United States) 7 of 7
Year (2007) 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-08 Pee Dee Isotopes

Myrtle Beach, South Carolina, United States

Pee Dee Isotopes, Inc. is a radiopharmaceutical company.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-05 Triad Isotopes - Radiopharmacy Business

United States

Triad Isotopes, Inc. - Radiopharmacy Business is the second largest radiopharmacy network in the US with more than 50 pharmacies, distributing nuclear medicine products to the largest National GPOs, regional health systems, stand-alone imaging centres, cardiologists and hospitals.

Sell -
Mergr

Product

Company

Legal